Hospital PUC-CAMPINAS

Campinas, São Paulo 13060-904

0 studies enrolling now · 4 studies all time

What they study most

COVID-19, SARS-CoV Infection, Type 2 Diabetes

Studies at this site

• A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin — Completed
• VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study — Completed
• A Study of Baricitinib (LY3009104) in Participants With COVID-19 — Completed
• A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes — Completed